Board of Directors

James T. Treace

Chairman of the Board

James T. Treace has served as the chairman of our board of directors since June 2014. Mr. Treace has served as the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company, since October 2000. Before that, from November 1999 to October 2000, Mr. Treace served as President of Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT). From April 1996 to November 1999, Mr. Treace served as Chief Executive Officer, President and Chairman of the board of directors of Xomed Surgical Products, Inc. (NASDAQ: XOMD), until it was acquired by Medtronic plc. From July 1993 to April 1996, Mr. Treace co-founded and served as the Chief Executive Officer and Chairman of the Board at TreBay Medical Corp., an orthopaedic and microsurgical device company. From September 1981 to July 1990, he served as President and Chief Executive Officer of Concept, Inc. (NASDAQ: CCPT), now known as Conmed Linvatec (NYSE: CNMD) and from June 1966 to September 1981 as Executive Vice President of Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace previously served as Chairman of the Boards of Kyphon, Inc. (NASDAQ: KYPH), now part of Medtronic plc, Wright Medical, acquired by Stryker Corporation (NYSE: SYK) in November 2020, American Medical Systems, Inc. (NASDAQ: AMMD), now part of Endo Pharmaceuticals (NASDAQ: ENDP), and Keystone Dental, Inc., a privately-held dental implant company.

John T. Treace

CEO, Founder, and Board Member

John T. Treace has over 25 years of experience in medical device marketing, sales, and general management. Mr. Treace founded our company in January 2014 and has served as our Chief Executive Officer and a member of our board of directors since our inception. Mr. Treace is the former Senior Vice President of US Sales and Global Marketing for Wright Medical Group, Inc., a medical device company, acquired by Stryker Corporation (NYSE: SYK) in November 2020. During a 12-year tenure with Wright, Mr. Treace served in a number of senior management roles including Vice President, Biologics and Extremities and Senior Director of Biologics Marketing. Before that, Mr. Treace held positions at Xomed Surgical Products, Inc., including as Director of Marketing and as Senior Product Manager, and with TreBay Medical Corp as Advertising & Marketing Director.  Mr. Treace also served on the board of directors of ENTrigue Surgical, acquired by Arthrocare Corporation in July 2013. Mr. Treace holds a B.S. in Finance from Seattle University.

John K. Bakewell

Board Member

John K. Bakewell has served as a member of our board of directors since November 2020. He has served in senior executive roles for nearly three decades, building and executing business strategies for growth companies across the medical device, specialty pharmaceuticals, diagnostics and healthcare provider sectors, while also serving on public- and private-company boards. His professional experience includes serving for nine years as Executive Vice President and Chief Financial Officer of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020, from its private equity-backed reorganization through the company's initial public offering, multiple years of industry-leading growth and creation of its industry ­ leading lower extremities franchise. Additionally, Mr. Bakewell served in Chief Financial Officer roles at Cyberonics Inc., now part of LivaNova PLC (NASDAQ: LIVN); Lantheus Holdings, Inc. (NASDAQ: LNTH); Exact Sciences Corporation (NASDAQ: EXAS), a molecular diagnostics company; and RegionalCare Hospital Partners, Inc., now part of LifePoint Health. Mr. Bakewell currently serves on the board of directors of Neuronetics, Inc. (NASDAQ: STIM), a medical technology company, Xtant Medical Holdings, Inc. (NASDAQ: XTNT), a medical device company, and Impulse Dynamics, N.V., a privately-held medical device company offering a therapy for heart failure patients. He has previously served on several other public and private company boards, including Entellus Medical, Inc., now part of Stryker Corporation (NYSE: SYK); ev3, Inc., now part of Medtronic pie. (NYSE: MDT); and Corindus Vascular Robotics, Inc., now a Siemens Healthineers company. He began his career as a Certified Public Accountant with seven years, collectively, at KPMG and Ernst & Young. He holds a BA in Accounting from the University of Northern Iowa.

F. Barry Bays

Board Member

F. Barry Bays has served as a member of our board of directors since June 2014. From January 2000 to June 2008, he served in various senior leadership roles with Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020, including as Executive Chairman from June 2004 to October 2005, and again from April 2006 to June 2008, and as President and Chief Executive Officer from January 2000 to June 2004, and again from October 2005 to April 2006. From 1996 to 2000, Mr. Bays served as the Chief Operating Officer of Xomed Surgical Products, Inc., acquired by Medtronic plc (NYSE: MDT) in 1999. Mr. Bays has also served in leadership roles at TreBay Medical Corp., Concept, Inc., now known as Conmed Linvatec (NYSE: CNMD), and Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Bays holds a B.S. in Mechanical Engineering from Christian Brothers University.

Lance A. Berry

Board Member

Lance A. Berry has served as a member of our board of directors since October 2022. Mr. Berry has nearly two decades of financial leadership experience in the medical device industry. Mr. Berry joined Wright Medical Group N.V. in 2002 as Corporate Controller and was promoted to various roles culminating in the roles of Senior Vice President and Chief Financial Officer from December 2009 to January 2019 and Executive Vice President, Chief Financial and Operations Officer from January 2019 to November 2020. Before joining Wright Medical, he was an accountant in the auditing division of Arthur Andersen, LLP, from 1995 to 2002, where he held various positions of increasing responsibility, most recently as Audit Manager. He currently serves on the board of directors of Vapotherm (NYSE: VAPO), a publicly traded developer and manufacturer of advanced respiratory technology, and Priveterra Acquisition Corp (NASDAQ: PMGMU), a medical technology SPAC. Mr. Berry is a Certified Public Accountant (inactive) and received both a bachelor’s degree in accounting and his master’s degree in accounting from the University of Mississippi.

Lawrence W. Hamilton

Board Member

Lawrence W. Hamilton, MPA, Ed.S., SPHR, CCP, BCC, has served as a member of our board of directors since November 2020. Mr. Hamilton has served as an Executive Coach and Adjunct Faculty with the Center for Creative Leadership at Eckerd College since September 2008. He also manages a private executive coaching and HR consulting practice, Hamilton Consulting. From July 1993 to July 2006, Mr. Hamilton served in various roles at Tech Data Corporation, a technology distributor with over 11,000 associates worldwide, most recently as Senior Vice President, Human Resources.  He also served as Vice President of Human Resources and Administration at Linvatec and in a variety of human resource management positions at Bristol-Myers Squibb Company (NYSE: BMY). Mr. Hamilton has also previously served as a member of the board of directors of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020, and HomeBanc Mortgage (NYSE: HBMC). Mr. Hamilton holds a BA in Political Sciences from Fisk University, an MPA (Labor) Policy from the University of Alabama and an Ed.S. in Human Resources Development from George Washington University. Mr. Hamilton is a certified Senior Professional in Human Resources and holds the Certified Compensation Professional designation from the American Compensation Association.

Mr. Hamilton was also appointed to the board of the National Association of State Boards of Accountancy (NASBA) Center for the Public Trust (CPT), the University of South Florida, St. Petersburg Campus Board of Directors, and the Carter-Edison Advisory Board.

Betsy Hanna

Board Member

Elizabeth "Betsy" Hanna has served as a member of our board of directors since October 2021. Since March 2022, Ms. Hanna has served as Executive Vice President and Chief Commercial Officer of Agendia, Inc., a provider of molecular diagnostic test solutions. Before joining Agendia, Ms. Hanna served as President and Chief Executive Officer and a board member of Clinical Genomics, Inc., a provider of cancer diagnostic solutions, since January 2019. From October 2018 until her promotion, she was Chief Commercial Officer of Clinical Genomics. From December 2014 to September 2018, she served as President and Chief Operating Officer of Origin, Inc., a clinical-stage biotech company. From 2006 to April 2014, Ms. Hanna held positions of increasing responsibility at Johnson & Johnson, including as Vice President, Global Strategic Marketing -Acuvue Brand from October 2012 to April 2014, Vice President, Europe, Mideast and Africa at J&J Diagnostics from January 2010 to October 2012, and Vice President, Worldwide Marketing - Ortho Clinical Diagnostics from October 2006 to December 2009. She also served as a member of the Global Management Board for J&J Vision Care from October 2012 to April 2014. Ms. Hanna has a B.S. in Chemical Engineering from the University of Illinois and an M.B.A. from Harvard Business School.

Deepti Jain

Board Member

Deepti Jain has served as a member of our board of directors since October 2021. Ms. Jain served as President of lngenioRX, the pharmacy benefit management division of Anthem, Inc. (NYSE: ANTM), a publicly-traded health benefits company, from January 2019 to December 2020. She served as Chief Operating Officer for Pharmacy Solutions for Anthem from 2014 to 2018. From 1998 to 2012, Ms. Jain held positions of increasing responsibility, including Senior Vice President & Chief Financial Officer of the Health Plan Division from 2010 to 2012, with Medco Health Solutions, Inc., a publicly ­ traded pharmacy benefits management company which was acquired by Express Scrip ls in April 2012. From April 2019 to November 2020, she served on the board of directors or the Pharmaceutical Care Management Association (PCMA), the national association representing America's pharmacy benefit managers. Ms. Jain currently serves on the Board or Directors of Tactile Systems Technology, Inc. (NASDAQ: TCMD), a Nasdaq publicly traded medical device corporation. Ms. Jain has a B.A. in Philosophy & Music from Dayanand Anglo Vedic College, India, an M.A. in English Literature from Guru Nanak Dev University, India, and an M.B.A., Finance & Investments from Baruch College, NYC.

Jane E. Kiernan

Board Member

Jane E. Kiernan has served as a member of our board of directors since October 2022. Ms. Kiernan has over 30 years of executive and management leadership in healthcare with both public and private companies. She joined Surgimatix, Inc., a privately-held medical device company pioneering a novel suture-based soft tissue fixation technology for minimally invasive surgical procedures, as Chief Business Officer in May 2020 and became its Chief Executive Officer and a board member in February 2022. In January 2018, Ms. Kiernan cofounded K2 Biotechnology Ventures, an organization engaged in developing and commercializing university and medical center innovations in partnership with venture capital, healthcare corporations and philanthropic healthcare foundation partners. From October 2010 to May 2017, Kiernan served as the CEO of Salter Labs, a manufacturer of specialty respiratory and airway management medical devices. From 2001 to September 2010, Kiernan held executive and general management positions with both Baxter Healthcare Corporation and Allegiance Healthcare Corporation. She currently serves on the board of directors of Axonics, Inc. (NASDAQ: AXNX), a publicly traded medical technology company developing products for women with bladder and bowel dysfunction. She previously served on the board of directors of Salona Global Medical Device Corp (TSXV: SGMD), a publicly traded medical device company, Endologix, Inc. (OTC: ELGXQ), a publicly-traded provider of minimally invasive treatments of aortic disorders, and American Medical Systems, a publicly traded life sciences company acquired by Endo Pharmaceuticals. Kiernan holds a B.S. degree in business from Southern Methodist University.

Richard W. Mott

Board Member

Richard W. Mott has served as a member of our board of directors since March 2015. He is currently the principal of Walkabout Consulting, LLC, a management consulting and private equity firm, as well as a director and owner of VFD Technologies, a private equity firm that invests in high performance materials and medical device manufacturing businesses. Mr. Mott served as the Chairman and Interim CEO of Endologix, LLC, a medical device company, from October 2020 through November 2021. From September 2002 to November 2007, Mr. Mott served as President, CEO and Director of Kyphon Inc., a NASDAQ. listed global medical device company through its acquisition by Medtronic pie (NYSE: MDT). From 1993 to 2002, Mr. Mott held various management positions at Wilson Greatbatch Technologies, Inc. and Bristol-Myers Squibb Co. (NYSE: BMY). From May 2008 to December 2017, Mr. Mott served as a member of the board of directors of Silk Road Medical, Inc. (NASDAQ: SILK), a medical device company. Mr. Mott currently serves on the board of various private companies, including the medical device companies Endologix, LLC, Relievant Medsystems, Inc., CeQur Corporation and Arsenal Medical, Inc. He is the previous recipient of the Ernst & Young Entrepreneur of the Year Award, the Frost & Sullivan Technology Leadership of the Year Award, and the Phoenix Lifetime Achievement Award. He holds a B.S. in Ceramic Engineering from Alfred University, and is a Graduate of Harvard University's Advanced Management Program.

Thomas E. Timbie

Board Member

Thomas E. Timbie has served as a member of our board of directors since June 2014 and served as our Chief Financial Officer from July 2014 to October 2015. Mr. Timbie is the President of Timbie & Company, LLC, a financial and management consulting firm he founded in 2000. Mr. Timbie has over 30 years of financial experience primarily in the medical device market. During 2005, as the interim Chief Financial Officer of ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT), Mr. Timbie helped lead ev3 through their initial public offering. He was also the Chief Financial Officer of Xomed Surgical Products, Inc., including during its initial public offering in 1996, and continuing in that role until Xomed was acquired by Medtronic plc (NYSE: MDT) in 1999. Prior to Xomed, Mr. Timbie was the Chief Financial Officer of TreBay Medical Corp., a private orthopaedic and microsurgical device company, and the Director of Accounting at Concept Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (NYSE: CNMD). Timbie has also previously served as a member of the board of directors of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., until its acquisition by Covidien (part of Medtronic plc. (NYSE: MDT)); and American Medical Systems, Inc., now part of Endo Pharmaceuticals (NASDAQ: ENDP). Mr. Timbie holds a B.S. in Accounting from University of Florida, an M.B.A. from Stetson University and is a certified public accountant (current status inactive). Mr. Timbie has also served as a board member and audit committee chairman of several public and private medical device companies including Wright Medical, Inc. acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT); Acclarent, Inc., acquired by Johnson & Johnson (NYSE: JNJ) in 2010; and American Medical Systems, Inc. acquired by Endo Pharmaceuticals (NASDAQ: ENDP) in 2011. Mr. Timbie is also a former board member and audit committee chairman of two health care services companies, LaVie Care Centers and RegionalCare Hospital Partners.